US 11,986,389 B2
Prosthetic cardiac valve devices, systems, and methods
Claudio Argento, Felton, CA (US); Andrew Backus, Santa Cruz, CA (US); and Alice Yang, Campbell, CA (US)
Assigned to Shifamed Holdings, LLC, Campbell, CA (US)
Filed by Shifamed Holdings, LLC, Campbell, CA (US)
Filed on Mar. 16, 2023, as Appl. No. 18/185,330.
Application 18/185,330 is a continuation of application No. 17/170,717, filed on Feb. 8, 2021, granted, now 11,672,657.
Application 17/170,717 is a continuation of application No. 16/594,946, filed on Oct. 7, 2019, granted, now 10,912,644, issued on Feb. 9, 2021.
Claims priority of provisional application 62/755,996, filed on Nov. 5, 2018.
Claims priority of provisional application 62/742,043, filed on Oct. 5, 2018.
Prior Publication US 2024/0041598 A1, Feb. 8, 2024
This patent is subject to a terminal disclaimer.
Int. Cl. A61F 2/24 (2006.01)
CPC A61F 2/2433 (2013.01) [A61F 2/2418 (2013.01); A61F 2/2427 (2013.01); A61F 2/2457 (2013.01); A61F 2/2466 (2013.01); A61F 2210/0014 (2013.01); A61F 2220/0008 (2013.01)] 20 Claims
OG exemplary drawing
 
1. A method for treating a diseased native valve in a patient, the method comprising: positioning an anchor on a first side of a native valve;
advancing the anchor from the first side of the native valve to a second side of the native valve such that the anchor is located only on the second side of the native valve;
rotating the anchor around one or more structures on the second side of the native valve;
positioning a frame structure in a collapsed configuration within the anchor; and
expanding the frame structure against the anchor to anchor the frame structure in the native valve.